The study, published in Frontiers in Genetics, was led by Songhang Wu and colleagues in the Department of Laboratory Medicine, and it tackles a problem that has long complicated reproductive genetic counseling. Chromosomal aberrations are well-established contributors to infertility, recurrent miscarriage, and failed implantation, and peripheral blood karyotyping remains the standard first-line test for detecting them. Yet the same G-banding technique that reveals a balanced translocation also flags inversions of chromosome 9, variations in heterochromatin on chromosomes 1, 9, and 16, and variants of the D and G group acrocentric chromosomes—changes so common in the general population that many geneticists consider them normal human diversity rather than pathology.

The numbers from the Fujian cohort make the scale of the problem vivid. Of the 7,530 patients, 552—7.33 percent—had some abnormal cytogenetic finding. But when the researchers separated their findings into two categories, only 246 cases, or 3.27 percent of the cohort, qualified as clinically relevant chromosomal abnormalities: numerical abnormalities of autosomes or sex chromosomes, structural rearrangements, sex reversal or disorders of sex development-related karyotypes, and marker chromosomes. The remaining 306 cases, 4.06 percent of all patients and 55.43 percent of every abnormal finding reported, were chromosomal polymorphisms. Had the laboratory simply reported all 552 as

The distinction matters because a karyotype report that lumps benign variants together with pathogenic rearrangements can send couples down unnecessary diagnostic paths, inflate anxiety, and distort the apparent value of cytogenetic testing. The Fujian team’s decision to count only the 246 clinically relevant findings as the primary diagnostic outcome—3.27 percent of the cohort—offers a more honest benchmark than the 7.33 percent raw abnormality rate that many laboratory audits report. It also gives counselors a concrete figure to cite when explaining to patients that a variant of heterochromatin, however unusual it looks under the microscope, is not by itself an explanation for infertility or pregnancy loss.

The methodological details of the study reinforce why karyotyping has endured despite the arrival of chromosomal microarrays and sequencing-based approaches. Peripheral blood lymphocytes were cultured for 72 hours, arrested in metaphase with colchicine, and stained with G-banding to produce the familiar striped chromosomes that cytogeneticists read band by band. The laboratory counted at least 20 metaphase cells per patient and analyzed at least five in detail, extending to 30 or more metaphases whenever mosaicism was suspected or an abnormal clone needed confirmation. This counting strategy is not arbitrary: low-level mosaicism can be missed entirely if too few cells are examined, and the probability of detecting a cell line present in 10 percent of lymphocytes rises steeply with the number of metaphases scored. The analyzed resolution exceeded 320 bands, and all karyotypes were described according to the International System for Human Cytogenomic Nomenclature, the standardized language that allows findings from different laboratories to be compared and archived.

That standardization matters because the study spans seven years of referrals, during which the indications for testing ranged from infertility and severe spermatogenic impairment to menstrual and endocrine abnormalities, congenital anomalies of reproductive organs, adverse pregnancy outcomes such as recurrent miscarriage and embryo arrest, and general genetic counseling requests. The researchers assigned each patient a clinical indication based on the referral diagnosis in the electronic medical record, and they excluded anyone with incomplete records or a history of radiation exposure, which can itself induce chromosomal damage and confound interpretation. This careful phenotyping set the stage for the study’s most statistically ambitious component: a correspondence analysis linking clinical manifestations to representative karyotypic findings.

Correspondence analysis is a technique borrowed from categorical statistics that turns a contingency table into a two-dimensional map, allowing researchers to see which categories cluster together and which stand apart. In this study, the first two dimensions captured 77.9 percent and 15.2 percent of the total inertia, meaning that nearly 93 percent of the association structure between phenotype and karyotype could be visualized in a single plot. The global chi-square test confirmed that the association was not due to chance: a statistic of 69.92 with 16 degrees of freedom yields a probability far below the conventional significance threshold. In practical terms, certain clinical presentations were non-randomly paired with certain cytogenetic findings—precisely the kind of pattern that phenotype-guided interpretation seeks to exploit.

The logic of phenotype-guided interpretation is straightforward. A balanced reciprocal translocation in either partner of a couple with recurrent miscarriage has a well-understood mechanism: during gamete formation, the rearranged chromosomes can segregate unbalanced, producing embryos with partial trisomies or monosomies that are incompatible with ongoing development. Sex chromosome numerical abnormalities, such as additional X chromosomes in males or a single X chromosome in females, connect directly to spermatogenic failure and primary ovarian insufficiency through documented disruptions of genes involved in gonadal development. When a karyotype finding matches the expected mechanism for the referral diagnosis, confidence in its clinical relevance rises, and the case for proceeding to prenatal diagnosis or preimplantation genetic testing becomes clear.

Conversely, the same logic helps demote findings whose relevance is doubtful. An inversion of chromosome 9, present in a small but substantial fraction of the general population, appears in karyotypes of infertile patients at rates that roughly mirror background frequency, and most studies have failed to establish it as an independent cause of reproductive failure. Similarly, variations in the size or staining intensity of the satellite regions and short arms of the acrocentric D and G group chromosomes, and pericentromeric heterochromatin variants on chromosomes 1, 9, and 16, are inherited benign markers that follow Mendelian transmission within families. Reporting such variants as abnormal findings without qualification risks pathologizing normal human variation, and the Fujian study’s finding that these polymorphisms constituted a majority of all abnormal results quantifies how large this interpretive burden can be in a real clinical population.

The study also illustrates the continuing division of labor between cytogenetics and molecular methods. G-banding surveys the entire genome at a resolution of several million base pairs and excels at detecting balanced rearrangements—reciprocal translocations and inversions—that leave the total amount of chromosomal material unchanged and are therefore invisible to copy-number-based technologies such as chromosomal microarray. At the same time, karyotyping cannot resolve submicroscopic deletions, duplications, or uniparental disomy, and some apparently balanced rearrangements disrupt genes at their breakpoints in ways that only sequencing can reveal. This is why the authors emphasize that phenotype-guided interpretation should help identify which patients require additional molecular confirmation or multidisciplinary counseling rather than replacing karyotyping altogether. A couple in which one partner carries a balanced translocation, for example, may benefit from reproductive options that depend on knowing the exact breakpoints, information that follow-up molecular testing can supply.

The population context of the study deserves note as well. All participants were drawn from a Chinese Han population attending a single large tertiary center in Fujian province over a seven-year period, which gives the figures internal consistency while limiting how directly they can be generalized. Polymorphism frequencies vary across populations, and referral patterns—which indications prompt a karyotype, at what stage of the fertility workup it is ordered—differ between health systems. Nevertheless, the central finding that benign variants outnumber clinically relevant abnormalities among positive karyotype results is consistent with the long-standing observation that heterochromatic regions of the human genome are highly variable and that cytogeneticists have debated their significance for decades.

For laboratories, the practical lesson is one of reporting discipline. When a polymorphic variant is detected, the report should state clearly that it is a population variant of uncertain or no clinical significance for the presenting complaint, rather than listing it alongside pathogenic findings without distinction. For counselors, the lesson is one of expectation management: patients should understand before testing that a positive-sounding result may still be benign, and that the diagnostic yield of karyotyping in reproductive populations, properly counted, is closer to three percent than seven. For researchers, the correspondence analysis framework offers a template that other centers could replicate with their own cohorts, testing whether the phenotype-karyotype associations hold across populations and whether they sharpen as molecular follow-up data accumulate. Taken together, the study does not diminish the value of karyotyping; it refines it, arguing that the test’s usefulness depends on interpreting what it finds in light of why it was ordered.

Subject of Research: Chromosomal abnormalities and polymorphisms detected by karyotyping in reproductive genetic counseling

Article Title: Clinically relevant chromosomal abnormalities and chromosomal polymorphisms in 7,530 patients undergoing reproductive genetic counseling: a retrospective cytogenetic study in a Chinese Han population

Article References: Clinically relevant chromosomal abnormalities and chromosomal polymorphisms in 7,530 patients undergoing reproductive genetic counseling: a retrospective cytogenetic study in a Chinese Han population. (n.d.). https://doi.org/10.3389/fgene.2026.1947419

Image Credits: AI Generated

DOI: 10.3389/fgene.2026.1947419

Keywords: karyotyping, chromosomal polymorphisms, reproductive genetics, infertility, recurrent miscarriage, G-banding, correspondence analysis, Klinefelter syndrome, Turner syndrome, balanced translocation, genetic counseling, cytogenetics